KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Operating Leases (2019 - 2025)

Pacira BioSciences has reported Operating Leases over the past 7 years, most recently at $46.0 million for Q4 2025.

  • Quarterly results put Operating Leases at $46.0 million for Q4 2025, up 3.07% from a year ago — trailing twelve months through Dec 2025 was $46.0 million (up 3.07% YoY), and the annual figure for FY2025 was $46.0 million, up 3.07%.
  • Operating Leases for Q4 2025 was $46.0 million at Pacira BioSciences, up from $38.8 million in the prior quarter.
  • Over the last five years, Operating Leases for PCRX hit a ceiling of $75.7 million in Q2 2022 and a floor of $38.8 million in Q3 2025.
  • Median Operating Leases over the past 5 years was $65.1 million (2022), compared with a mean of $61.6 million.
  • Biggest five-year swings in Operating Leases: soared 87.04% in 2021 and later plummeted 31.94% in 2025.
  • Pacira BioSciences' Operating Leases stood at $71.7 million in 2021, then fell by 9.65% to $64.8 million in 2022, then dropped by 15.43% to $54.8 million in 2023, then fell by 18.54% to $44.6 million in 2024, then grew by 3.07% to $46.0 million in 2025.
  • The last three reported values for Operating Leases were $46.0 million (Q4 2025), $38.8 million (Q3 2025), and $50.9 million (Q2 2025) per Business Quant data.